- Home
- Industry Reports
- Biotechnology
- Healthcare
- Middle East & Africa Biomaterials Market – Size, Outlook, Trends and Forecast (2024 – 2032)
Biomaterials are the substance which is used in medical procedures such as tissues replacement or a diagnostic and to repair damaged organs. Biomaterials either may be artificial or natural materials which will relate biological systems for cardiovascular, orthopedic, and neurological disorders. These have the number of applications in the biomineralization, biomolecules, biotechnology, and Biomed engineering.
The Middle East & Africa Biomaterials Market Segments Size & Growth:
The Middle East & Africa Biomaterials Market is accounted for $ 4.59 billion in 2017 and expected to grow at a CAGR of 12.9% to reach $8.68 billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth are by the superior properties of biomaterial, increase in inventions in biomaterials, rise in ageing population, high per capita income. However, safety issues and compatibility hinder the growth of the biomaterials market.
The Middle East & Africa Biomaterials Market Segments Share:
The Middle East & Africa Biomaterials Market is categorised into by specialty which consists of cardiology, neurology, orthopedics, dental, and gynecology. Cardiology and orthopedics have the most significant share due to increase in cardiovascular diseases and demand for orthopedic surgeries. On the basis of the type of materials, biomaterials market is classified by bioactive material, bioinert material, and a bioresorbable material. Bioinert material has the highest market because of demand for orthopedic procedures to support bones and their replacements.
On the basis of Geography, South Africa is dominating the biomaterials market and the growth in Middle East & Africa is mainly attributed to rising demand for cardiovascular diseases and orthopedic surgeries. Furthermore, Middle East is witnessing the fastest growth during the forecast period, due to the rise in funds offering for biomaterials.
The Middle East & Africa Biomaterials Market Segments Trends:
- Corbion N.V. has developed a bioplastic material PLA (polylactic acid) made from sugarcane and sugar beets which helps in decreasing carbon footprints.
- In February 2017, Dentsply Tulsa and Dentsply Maillefer have been combined to form a unit know as Dentsply Sirona Endodontics to develop better root treatments with less number of steps.
The Middle East & Africa Biomaterials Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- BASF SE
- Berkeley Advanced Biomaterials, Inc.
- Celsense Corporation
- Wright Medical Group, Inc.
- Biomet, Inc.
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increase in inventions in biomaterials
4.1.2 Rise in ageing population
4.1.3 High per capita income
4.2 Restraints
4.2.1 Compatibility issues
4.2.2 Safety regulations
4.3 Opportunities
4.3.1 Growing Healthcare industry
4.3.2 Increase in free-trades
4.4 Challenges
4.4.1. Limitations of biomaterial products
Chapter 5 Middle East & Africa Biomaterials Market – By Specialty
5.1 Cardiology
5.2 Neurology
5.3 Orthopaedics
5.4 Dental
5.5 Gynaecology
5.6 Others
Chapter 6 Middle East & Africa Biomaterials Market – By Type of Material
6.1 Bioactive material
6.2 Bioinert material
6.3 Bioresorbable material
Chapter 7 Middle East & Africa Biomaterials Market – By Geography
7.1 Introduction
7.2. Middle East & Africa
7.2.1. The Middle East
7.2.2. Africa
Chapter 8 Middle East & Africa Biomaterials Market – Company Profiles
8.1. AdvanSource Biomaterials Corp
8.2. Royal DSM
8.3. BASF SE
8.4. Dentsply
8.5. Zimmer Biomet Holdings, Inc.
8.6. Oasmia
8.7. Biomet, Inc.
8.8. Wright Medical Group, Inc.
8.9. Bayer AG
8.10. Celsense Corporation
8.11. Invibio Ltd.
8.12. DuPont
8.13. Corbion N.V.
8.14. Midatech
8.15. Berkeley Advanced Biomaterials, Inc.
Chapter 9 Middle East & Africa Biomaterials Market – Competitive Landscape
9.1. Market Share Analysis
9.2. Strategies Adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 10 Market Insights
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
Chapter 11 Appendix
11.1 List of Tables
11.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Regional Report
$2,160.00 – $7,200.00
- EUR: €2,016.05 - €6,720.18
- INR: ₹180,072.11 - ₹600,240.36
- AED: د.إ7,927.20 - د.إ26,424.00
- GBP: £1,726.61 - £5,755.36
Description
Regional Reports
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Biomaterials are the substance which is used in medical procedures such as tissues replacement or a diagnostic and to repair damaged organs. Biomaterials either may be artificial or natural materials which will relate biological systems for cardiovascular, orthopedic, and neurological disorders. These have the number of applications in the biomineralization, biomolecules, biotechnology, and Biomed engineering.
The Middle East & Africa Biomaterials Market Segments Size & Growth:
The Middle East & Africa Biomaterials Market is accounted for $ 4.59 billion in 2017 and expected to grow at a CAGR of 12.9% to reach $8.68 billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth are by the superior properties of biomaterial, increase in inventions in biomaterials, rise in ageing population, high per capita income. However, safety issues and compatibility hinder the growth of the biomaterials market.
The Middle East & Africa Biomaterials Market Segments Share:
The Middle East & Africa Biomaterials Market is categorised into by specialty which consists of cardiology, neurology, orthopedics, dental, and gynecology. Cardiology and orthopedics have the most significant share due to increase in cardiovascular diseases and demand for orthopedic surgeries. On the basis of the type of materials, biomaterials market is classified by bioactive material, bioinert material, and a bioresorbable material. Bioinert material has the highest market because of demand for orthopedic procedures to support bones and their replacements.
On the basis of Geography, South Africa is dominating the biomaterials market and the growth in Middle East & Africa is mainly attributed to rising demand for cardiovascular diseases and orthopedic surgeries. Furthermore, Middle East is witnessing the fastest growth during the forecast period, due to the rise in funds offering for biomaterials.
The Middle East & Africa Biomaterials Market Segments Trends:
- Corbion N.V. has developed a bioplastic material PLA (polylactic acid) made from sugarcane and sugar beets which helps in decreasing carbon footprints.
- In February 2017, Dentsply Tulsa and Dentsply Maillefer have been combined to form a unit know as Dentsply Sirona Endodontics to develop better root treatments with less number of steps.
The Middle East & Africa Biomaterials Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- BASF SE
- Berkeley Advanced Biomaterials, Inc.
- Celsense Corporation
- Wright Medical Group, Inc.
- Biomet, Inc.
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s Five Force Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Increase in inventions in biomaterials
4.1.2 Rise in ageing population
4.1.3 High per capita income
4.2 Restraints
4.2.1 Compatibility issues
4.2.2 Safety regulations
4.3 Opportunities
4.3.1 Growing Healthcare industry
4.3.2 Increase in free-trades
4.4 Challenges
4.4.1. Limitations of biomaterial products
Chapter 5 Middle East & Africa Biomaterials Market – By Specialty
5.1 Cardiology
5.2 Neurology
5.3 Orthopaedics
5.4 Dental
5.5 Gynaecology
5.6 Others
Chapter 6 Middle East & Africa Biomaterials Market – By Type of Material
6.1 Bioactive material
6.2 Bioinert material
6.3 Bioresorbable material
Chapter 7 Middle East & Africa Biomaterials Market – By Geography
7.1 Introduction
7.2. Middle East & Africa
7.2.1. The Middle East
7.2.2. Africa
Chapter 8 Middle East & Africa Biomaterials Market – Company Profiles
8.1. AdvanSource Biomaterials Corp
8.2. Royal DSM
8.3. BASF SE
8.4. Dentsply
8.5. Zimmer Biomet Holdings, Inc.
8.6. Oasmia
8.7. Biomet, Inc.
8.8. Wright Medical Group, Inc.
8.9. Bayer AG
8.10. Celsense Corporation
8.11. Invibio Ltd.
8.12. DuPont
8.13. Corbion N.V.
8.14. Midatech
8.15. Berkeley Advanced Biomaterials, Inc.
Chapter 9 Middle East & Africa Biomaterials Market – Competitive Landscape
9.1. Market Share Analysis
9.2. Strategies Adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
Chapter 10 Market Insights
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
Chapter 11 Appendix
11.1 List of Tables
11.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.